Successful endovascular treatment of bilateral renal artery paradoxical embolus by a modified standard technique.
Goueffic
Yann
Y
Service de Chirurgie Vasculaire Hopital Laennec, Saint Herblain, France.
Carbajal
Roger
R
Burban
Marc
M
Blancho
Gilles
G
D058186:Acute Kidney Injury / Q000209:etiology* / Q000628:therapy; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D002404:Catheterization; D003131:Combined Modality Therapy; D017128:Embolectomy / Q000379:methods*; D019320:Embolism, Paradoxical / Q000188:drug therapy / Q000209:etiology / Q000601:surgery*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006344:Heart Septal Defects, Atrial / Q000150:complications* / Q000601:surgery; D006406:Hematoma / Q000139:chemically induced / Q000150:complications; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007238:Infarction / Q000209:etiology / Q000601:surgery*; D007668:Kidney / Q000098:blood supply*; D007676:Kidney Failure, Chronic; D011655:Pulmonary Embolism / Q000150:complications; D012077:Renal Artery / Q000601:surgery*; D006435:Renal Dialysis; D015912:Thrombolytic Therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use; D016306:Vena Cava Filters
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin; D014568:Urokinase-Type Plasminogen Activator